RT Journal Article
SR Electronic
T1 Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 219
DO 10.1186/s40425-019-0679-9
VO 7
IS 1
A1 Shitara, Kohei
A1 Satoh, Taroh
A1 Iwasa, Satoru
A1 Yamaguchi, Kensei
A1 Muro, Kei
A1 Komatsu, Yoshito
A1 Nishina, Tomohiro
A1 Esaki, Taito
A1 Hasegawa, Jun
A1 Kakurai, Yasuyuki
A1 Kamiyama, Emi
A1 Nakata, Tomoko
A1 Nakamura, Kota
A1 Sakaki, Hayato
A1 Hyodo, Ichinosuke
YR 2019
UL http://jitc.bmj.com/content/7/1/219.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.